Shandong Jincheng Pharmaceutical Group (300233.SZ) announced that its wholly-owned subsidiary Peking Jincheng Tail Pharmaceutical Co., Ltd. and the controlling subsidiary...
According to the Zhito Finance APP, Shandong Jincheng Pharmaceutical Group (300233.SZ) announced that its wholly-owned subsidiary Peking Jincheng Taili Pharmaceutical Co., Ltd. and its holding subsidiary Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd. have respectively received the "Drug Registration Certificate" issued by the National Medical Products Administration, with product names being: Posaconazole enteric-coated tablets and Cefoperazone sodium for injection.
